News | December 21, 2022
Indira IVF forays into diagnostic business with ‘Indira Pathlabs’
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
The teams will assist the state health authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
The approval further strengthens the Potassium Chloride franchise for the company.
The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.
Aster Pharmacy will be operated by GD Assist Limited in Bangladesh.
The #pledgemyeyes initiative reached out to over 30 million people across the country and the website registered 3X more pledges compared to the present numbers
Rymti is indicated in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, plaque psoriasis, and paediatric plaque psoriasis
To mark the occasion, Integrated Pharmaceutical Database Management System 2.0 (IPDMS 2.0), an integrated responsive cloud-based application developed by NPPA with technical support from C-DAC will be launched
Subscribe To Our Newsletter & Stay Updated
